Pathogen-reduced platelets for the prevention of bleeding (protocol)
This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the effectiveness and safety of pathogen-reduced platelets for the prevention of bleeding in all patients requiring platelet transfusion(s).
Päätekijät: | Butler, C, Doree, C, Estcourt, L, Stanworth, S, Brunskill, S, Hopewell, S, Murphy, M |
---|---|
Aineistotyyppi: | Journal article |
Julkaistu: |
2011
|
Samankaltaisia teoksia
-
Pathogen-reduced platelets for the prevention of bleeding.
Tekijä: Butler, C, et al.
Julkaistu: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
Tekijä: Butler, C, et al.
Julkaistu: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
Tekijä: Estcourt, L, et al.
Julkaistu: (2017) -
Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
Tekijä: Wardrop, D, et al.
Julkaistu: (2016) -
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Tekijä: Estcourt, L, et al.
Julkaistu: (2016)